| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 659938 | 97051005 | MIRAPEXIN 0,7 mg COMPRIMIDOS | MIRAPEXIN 0,7 mg COMPRIMIDOS, 30 comprimidos | 0,7 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97051005/97051005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97051005/97051005_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | BOEHRINGER INGELHEIM ESPANA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 659946 | 97051006 | MIRAPEXIN 0,7 mg COMPRIMIDOS | MIRAPEXIN 0,7 mg COMPRIMIDOS, 100 comprimidos | 0,7 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97051006/97051006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97051006/97051006_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | BOEHRINGER INGELHEIM ESPANA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 659646 | 69149 | DISLAVEN RETARD 150 mg CAPSULAS DE LIBERACION PROLONGADA EFG | DISLAVEN RETARD 150 mg CAPSULAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 150 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69149/69149_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69149/69149_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16612 | ADAMED LABORATORIOS S.L.U. | 2007-07-25 | 1 | 1 | 1 | 2007-07-25 | 2007-07-25 | 1 | 2014-09-17 | View Edit Delete | ||||||||||||
| 659647 | 69150 | DISLAVEN RETARD 75 mg CAPSULAS DE LIBERACION PROLONGADA EFG | DISLAVEN RETARD 75 mg CAPSULAS DE LIBERACION PROLONGADA EFG , 30 cápsulas | 75 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69150/69150_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69150/69150_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16612 | ADAMED LABORATORIOS S.L.U. | 2007-07-25 | 1 | 1 | 1 | 2007-07-25 | 2007-07-25 | 1 | 2011-03-04 | View Edit Delete | ||||||||||||
| 660013 | 69345 | VALS 320 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | VALS 320 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 320 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69345/69345_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69345/69345_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2007-10-22 | 1 | 1 | 1 | 2007-10-22 | 2007-10-22 | 0 | 2011-10-17 | View Edit Delete | ||||||||||||
| 658845 | 68671 | GESTINYL 20/75 microgramos COMPRIMIDOS RECUBIERTOS | GESTINYL 20/75 microgramos COMPRIMIDOS RECUBIERTOS, 21 comprimidos | 0,075 mg/0,02 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68671/68671_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68671/68671_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | LABORATORIOS EFFIK S.A. | 2007-04-24 | 1 | 1 | 1 | 2007-04-24 | 2007-04-24 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 658846 | 68671 | GESTINYL 20/75 microgramos COMPRIMIDOS RECUBIERTOS | GESTINYL 20/75 microgramos COMPRIMIDOS RECUBIERTOS, 63 (3 x 21) comprimidos | 0,075 mg/0,02 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68671/68671_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68671/68671_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | LABORATORIOS EFFIK S.A. | 2007-04-24 | 1 | 1 | 1 | 2007-04-24 | 2007-04-24 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 659406 | 69015 | ALENDROFARM 70 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ALENDROFARM 70 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 4 comprimidos | 70 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69015/69015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69015/69015_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8730 | FARMALIDER S.A. | 2007-06-25 | 1 | 1 | 1 | 2007-06-25 | 2007-06-25 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 658780 | 68627 | NORFLOXACINO CINFA 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | NORFLOXACINO CINFA 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 14 comprimidos | 400 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68627/68627_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68627/68627_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-03-29 | 1 | 1 | 1 | 2007-03-29 | 2007-03-29 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659096 | 68823 | OLANZAPINA CINFA 2,5 mg COMPRIMIDOS EFG | OLANZAPINA CINFA 2,5 mg COMPRIMIDOS EFG, 28 comprimidos | 2,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68823/68823_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68823/68823_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-05-28 | 1 | 1 | 1 | 2007-05-28 | 2007-05-28 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 659104 | 68828 | OLANZAPINA CINFA 5 mg COMPRIMIDOS EFG | OLANZAPINA CINFA 5 mg COMPRIMIDOS EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68828/68828_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68828/68828_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-05-28 | 1 | 1 | 1 | 2007-05-28 | 2007-05-28 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 659105 | 68829 | OLANZAPINA CINFA 7,5 mg COMPRIMIDOS EFG | OLANZAPINA CINFA 7,5 mg COMPRIMIDOS EFG, 56 comprimidos | 7,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68829/68829_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68829/68829_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-05-28 | 1 | 1 | 1 | 2007-05-28 | 2007-05-28 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 659106 | 68830 | OLANZAPINA CINFA 10 mg COMPRIMIDOS EFG | OLANZAPINA CINFA 10 mg COMPRIMIDOS EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68830/68830_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68830/68830_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-05-28 | 1 | 1 | 1 | 2007-05-28 | 2007-05-28 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 659107 | 68830 | OLANZAPINA CINFA 10 mg COMPRIMIDOS EFG | OLANZAPINA CINFA 10 mg COMPRIMIDOS EFG, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68830/68830_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68830/68830_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-05-28 | 1 | 1 | 1 | 2007-05-28 | 2007-05-28 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 659477 | 69057 | LOSARTAN/HIDROCLOROTIAZIDA CINFA 50 mg/ 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN/HIDROCLOROTIAZIDA CINFA 50 mg/ 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 50 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69057/69057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69057/69057_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-06-29 | 1 | 1 | 1 | 2007-06-29 | 2007-06-29 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659517 | 69086 | TERAZOSINA CINFA 2 mg COMPRIMIDOS EFG | TERAZOSINA CINFA 2 mg COMPRIMIDOS EFG , 15 comprimidos | 2 mg | 5 | 15 | 10 | 15 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69086/69086_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69086/69086_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-06 | 1 | 1 | 1 | 2007-07-06 | 2007-07-06 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659518 | 69087 | TERAZOSINA CINFA 5 mg COMPRIMIDOS EFG | TERAZOSINA CINFA 5 mg COMPRIMIDOS EFG, 30 comprimidos | 5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69087/69087_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69087/69087_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-06 | 1 | 1 | 1 | 2007-07-06 | 2007-07-06 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659531 | 69093 | MELOXICAM CINFA 7,5 mg COMPRIMIDOS EFG | MELOXICAM CINFA 7,5 mg COMPRIMIDOS EFG, 20 comprimidos | 7,5 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69093/69093_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69093/69093_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-10 | 1 | 1 | 1 | 2007-07-10 | 2007-07-10 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659533 | 69094 | MELOXICAM CINFA 15 mg COMPRIMIDOS EFG | MELOXICAM CINFA 15 mg COMPRIMIDOS EFG, 20 comprimidos | 15 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69094/69094_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69094/69094_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-10 | 1 | 1 | 1 | 2007-07-10 | 2007-07-10 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659660 | 69161 | VENLAFAXINA RETARD CINFAMED 150 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA RETARD CINFAMED 150 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG , 30 cápsulas | 150 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69161/69161_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69161/69161_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-25 | 1 | 1 | 1 | 2007-07-25 | 2007-07-25 | 1 | 2018-06-15 | View Edit Delete |
Page 138 of 1036, showing 20 records out of 20704 total, starting on record 2741, ending on 2760